These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 7019841)

  • 41. [Early closure of ductus arteriosus with indomethacin].
    Kääpä P
    Klin Padiatr; 1985; 197(2):172. PubMed ID: 3990156
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [New aspects in the treatment of patent ductus arteriosus in premature newborns with respiratory insufficiency].
    Weninger M; Pollak A; Salzer-Muhar U; Simbruner G; Salzer HR; Rosenkranz M
    Z Geburtshilfe Perinatol; 1989; 193(5):226-9. PubMed ID: 2815899
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Indomethacin and furosemide in closure of ductus arteriosus].
    Vargas-Origel A; Cruz-Anguiano V; López-Montaño E
    Bol Med Hosp Infant Mex; 1986 Aug; 43(8):482-8. PubMed ID: 3755939
    [No Abstract]   [Full Text] [Related]  

  • 44. Can dopamine prevent the renal side effects of indomethacin? A prospective randomized clinical study.
    Baenziger O; Waldvogel K; Ghelfi D; Arbenz U; Fanconi S
    Klin Padiatr; 1999; 211(6):438-41. PubMed ID: 10592922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Furosemide does not prevent indomethacin-induced renal side effects in preterm infants.
    Romagnoli C; Zecca E; Papacci P; De Carolis MP; Giannini R; Gallini F; Tortorolo G
    Clin Pharmacol Ther; 1997 Aug; 62(2):181-6. PubMed ID: 9284854
    [TBL] [Abstract][Full Text] [Related]  

  • 46. B-type natriuretic peptide concentrations to guide treatment of patent ductus arteriosus.
    Attridge JT; Kaufman DA; Lim DS
    Arch Dis Child Fetal Neonatal Ed; 2009 May; 94(3):F178-82. PubMed ID: 18981033
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Closure of persistent ductus arteriosus in premature infants by drug therapy].
    Hencz P; Kertész E; Beviz J; Szeleczki T; Szekeres Z
    Orv Hetil; 1981 Oct; 122(41):2535-40. PubMed ID: 7033879
    [No Abstract]   [Full Text] [Related]  

  • 48. The effects of indomethacin on renal function and intracranial hemorrhage in infants with patent ductus arteriosus.
    Davis JM; Hendricks-Munoz KD; Hagberg D; Manning JA
    Dev Pharmacol Ther; 1990; 14(1):15-9. PubMed ID: 2311476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Indomethacin treatment of persistent ductus arteriosus in premature infants].
    Petersen S; Christensen NC; Lauridsen P; Pedersen SA; Ryssing E
    Ugeskr Laeger; 1983 Nov; 145(46):3564-7. PubMed ID: 6649140
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study.
    Gersony WM; Peckham GJ; Ellison RC; Miettinen OS; Nadas AS
    J Pediatr; 1983 Jun; 102(6):895-906. PubMed ID: 6343572
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors associated with permanent closure of the ductus arteriosus: a role for prolonged indomethacin therapy.
    Quinn D; Cooper B; Clyman RI
    Pediatrics; 2002 Jul; 110(1 Pt 1):e10. PubMed ID: 12093991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aspirin versus indomethacin treatment of patent ductus arteriosus in preterm infants with respiratory distress syndrome.
    van Overmeire B; Brus F; van Acker KJ; van der Auwera JC; Schasfoort M; Elzenga NJ; Okken A
    Pediatr Res; 1995 Dec; 38(6):886-91. PubMed ID: 8618789
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Management of persistent ductus arteriosus in the newborn with respiratory insufficiency].
    Hurtado del Rio D; Holden Barker AM; Pezzotti MA; Gutiérrez Bosque R; Archundia A; Pérez Mejia J; Carrillo H
    Arch Inst Cardiol Mex; 1979; 49(4):662-72. PubMed ID: 485672
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prophylactic indomethacin: factors determining permanent ductus arteriosus closure.
    Narayanan M; Cooper B; Weiss H; Clyman RI
    J Pediatr; 2000 Mar; 136(3):330-7. PubMed ID: 10700689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical profile and management of symptomatic patent ductus arteriosus in premature infants.
    Shenoi A; Narang A; Bhakoo ON; Bidwai PS
    Indian Pediatr; 1991 Feb; 28(2):125-30. PubMed ID: 2055626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of ductal diameter on surgical and medical closure of patent ductus arteriosus in preterm neonates: size matters.
    Tschuppert S; Doell C; Arlettaz-Mieth R; Baenziger O; Rousson V; Balmer C; Prêtre R; Dodge-Khatami A
    J Thorac Cardiovasc Surg; 2008 Jan; 135(1):78-82. PubMed ID: 18179922
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Indomethacin and persistent ductus arterious in the pre-term newborn infant with respiratory insufficiency].
    Hurtado del Río D; Holden Barker AM; Segura MA; Lozano González C
    Arch Inst Cardiol Mex; 1981; 51(1):83-8. PubMed ID: 7212861
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does indomethacin affect the control of breathing in premature infants?
    Yeh TF; Wilks A
    Dev Pharmacol Ther; 1989; 12(4):211-6. PubMed ID: 2766924
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The patent ductus arteriosus.
    Friedman WF; Fitzpatrick KM; Merritt TA; Feldman BH
    Clin Perinatol; 1978 Sep; 5(2):411-36. PubMed ID: 371899
    [No Abstract]   [Full Text] [Related]  

  • 60. Indomethacin therapy in infants with advanced postnatal age and patent ductus arteriosus.
    Achanti B; Yeh TF; Pildes RS
    Clin Invest Med; 1986 Nov; 9(4):250-3. PubMed ID: 3802612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.